SCLX Q1 2025 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q1 2025 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$5M-54.0% YoY

Gross Profit

$4M72.3% margin

Operating Income

-$28M-557.5% margin

Net Income

-$26M-521.2% margin

EPS (Diluted)

$-2.26

QoQ Revenue Growth

-66.4%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$6M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$79M

Total Liabilities

$290M

Stockholders' Equity

-$211M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$11M	-54.0%
Gross Profit	$4M	$7M	-48.6%
Operating Income	-$28M	-$19M	-43.2%
Net Income	-$26M	-$24M	-7.0%